FOLFOX for Colorectal Cancer: 108 Real Stories

108 stories match colorectal cancer and FOLFOX. 99 of them mention surgery.

Judy, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Judy's Survivor Story

Patient Info: Judy Perdue, Female, 40s

Judy Perdue was diagnosed with rectal cancer at age 44, completed 28 radiation treatments, 8 FOLFOX chemotherapy treatments, and surgery for a permanent ostomy, with lingering treatment side effects.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
Joanne, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Joanne's Survivor Story

Patient Info: Joanne Kowalec, Female, 40s | Stage III

Joanne Kowalec was diagnosed with Stage IIIB transverse colon cancer at age 40, had surgery followed by 12 rounds of FOLFOX, and reported being in remission.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
Pete, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Pete's Survivor Story

Patient Info: Pete Di Stefano, 40s | Stage III

Completed surgery and 3 months of FOLFOX chemotherapy for Stage IIIB transverse colon cancer; latest NED status is not reported, so this is best classified as survivorship / surveillance.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Sydney, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Sydney Stoner: Stage IIIB to Stage IV colon cancer with liver and lung involvement

Patient Info: Sydney Stoner, Female, Under 40 | Stage IV

Metastatic Site: Liver; lungs

Progressed from Stage IIIB colon cancer to Stage IV disease involving the liver and lungs; treated with surgery/ileostomy/reversal, FOLFOX/FOLFIRI, lung radiation, liver ablation/resection, capecitabine, and ongoing Lonsurf + Avastin.

Fight Colorectal Cancer
OutcomeSetback / Progression
A patient, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Sexual safety during FOLFOX treatment for Stage III rectal cancer

Patient Info: Anonymized, female, 50s | Stage III

A 54-year-old woman with Stage III rectal cancer raised a practical sexual-health question while receiving FOLFOX, leading to direct measurement of oxaliplatin exposure in vaginal secretions.

PubMed Central
OutcomeNot reported
JJ, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV MSI-High Colorectal Cancer: JJ's Patient Story

Patient Info: JJ, Male, Under 40 | Stage IV

Biomarkers: Lynch syndrome; microsatellite instability

Metastatic Site: Abdominal wall; lymph nodes throughout the body

At the latest scan, the main abdominal tumor remained stable. JJ had completed 126 rounds of chemo-immunotherapy and continued treatment every 3 weeks; small lung nodules were being watched but were not confirmed as metastases.

The Patient Story
OutcomeStable Disease / Ongoing Therapy
Janine, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Janine's Patient Story

Patient Info: Janine Stellacci, Female

Janine completed treatment and ileostomy reversal in 2024 and remained active in exercise and colorectal cancer screening advocacy.

Fight Colorectal Cancer
OutcomeNot reported
Adrienne, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Stage IV Colorectal Adenocarcinoma: Adrienne's Patient Story

Patient Info: Adrienne, Female | Stage IV

Metastatic Site: Liver

As of June 2026, Adrienne had Stage IV colon adenocarcinoma with liver metastases, had experienced liver recurrence after intensive multimodal treatment, and was back on FOLFIRI plus Avastin.

The Patient Story
OutcomeSetback / Progression
Haley, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Haley's Survivor Story

Patient Info: Haley Pollack, Female, Under 40 | Stage III

Years into survivorship after Stage IIIC colon cancer treated with surgery, CAPOX chemotherapy, and a recurrence-prevention clinical trial; later continued trial follow-up and advocacy for parents with cancer.

The Patient Story
OutcomeSurvivorship / Surveillance
Shelley, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Shelley's Survivor Story

Patient Info: Shelley, Female, 40s | Stage III

Shelley completed colectomy and adjuvant chemotherapy for Stage IIIB colon cancer and was in survivorship/recovery with lingering treatment effects and follow-up needs; explicit NED status is not stated.

The Patient Story
OutcomeSurvivorship / Surveillance
Lindsay, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lindsay's Patient Story

Patient Info: Lindsay, Female, Under 40 | Stage IV

Metastatic Site: Left ovary; lung spot

As of June 2026, Lindsay was living with Stage IV metastatic colon cancer after FOLFOX chemotherapy, surgery, maintenance chemotherapy, relapse, and a second surgery; exact later treatment details are limited in the extracted text.

The Patient Story
OutcomeLiving With Cancer
Lee, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lee's Patient Story

Patient Info: Lee, Male, 50s | Stage IV

Metastatic Site: Liver

Lee initially reached no evidence of disease after chemotherapy and right hemicolectomy, but the cancer recurred in the liver about 1 year later, requiring FOLFIRI and liver resection with major postoperative complications.

The Patient Story
OutcomeSetback / Progression
Justine, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Justine's Patient Story

Patient Info: Justine, Female, Under 40 | Stage IV

Metastatic Site: Liver

As of June 2026, Justine was living with Stage IV rectal cancer involving the liver after chemoradiation, major surgery, FOLFOX, and liver-directed local therapies.

The Patient Story
OutcomeLiving With Cancer
Ken, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Ken's Patient Story

Patient Info: Ken, Male, 50s | Stage IV

Metastatic Site: Liver

As of May 2026, Ken was more than 3 years into Stage IV colorectal cancer. He was not cancer-free or NED, but described the disease as minimal and manageable with surveillance, maintenance chemotherapy/targeted therapy, and occasional ablation.

The Patient Story
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Stage IV rectal mucinous adenocarcinoma with pancreatic metastasis: response to chemotherapy and staged surgery

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: CA 19-9 93.4 U/mL; CEA 3.4 ng/mL; pancreatic lesion biopsy consistent with colorectal origin

Metastatic Site: pancreas

As of May 2026, he had good clinical progress during 5 months of follow-up after staged treatment, including chemoradiation, FOLFOX, abdominoperineal resection, FOLFIRINOX, and Whipple resection of the pancreatic metastasis.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal cancer that spread through the lungs: complete remission after BRAF-targeted therapy

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: BRAF mutation; HER2-negative; microsatellite stable; no detectable KRAS or NRAS mutations

Metastatic Site: lungs (pulmonary lymphangitic carcinomatosis);…

After progression with recurrent lung metastases and a new pericardial effusion, she chose hospice care and died in February 2025, 19 months after diagnosis.

PubMed Central
OutcomeIn Memory
Nathan, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Nathan's Survivor Story

Patient Info: Nathan, Male, Under 40 | Stage IV

Metastatic Site: Liver; peritoneal membrane

Declared tumor-free after aggressive treatment for Stage IV colon cancer, including colectomy, FOLFOX chemotherapy, and HIPEC, while continuing to live with treatment effects, an ileostomy, neuropathy, and scan anxiety.

The Patient Story
OutcomeCancer-Free / NED
Mariana, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Mariana's Patient Story

Patient Info: Mariana, Female, Under 40 | Stage IV

Metastatic Site: Ovary; abdominal wall/peritoneum

Ongoing treatment for Stage IV colon cancer with good response during chemotherapy, allowing oxaliplatin to be stopped while continuing treatment every 2 weeks.

The Patient Story
OutcomeResponding Well
Helen, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Helen's Survivor Story

Patient Info: Helen, Female, 40s | Stage IV

Metastatic Site: Liver; pelvis

No active tumors / no evidence of disease after liver-directed treatment, liver surgery/ablation, colon resection, and hysterectomy, though she personally described herself as living with cancer and still planned cleanup treatment.

The Patient Story
OutcomeCancer-Free / NED
Meagan, who was diagnosed with Stage III Colorectal AdenocarcinomaColorectal Cancer

Stage III Colorectal Adenocarcinoma: Meagan's Survivor Story

Patient Info: Meagan, Female, Under 40 | Stage III

In remission after surgery and 6 months of FOLFOX for high-risk Stage IIIC sigmoid colon adenocarcinoma, with ongoing 6-month scan monitoring and survivorship challenges including scanxiety and neuropathy.

The Patient Story
OutcomeCancer-Free / NED
Kalei, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Kalei's Patient Story

Patient Info: Kalei, Female | Stage IV

Metastatic Site: Lungs

Living with Stage IV rectal cancer after lung metastases were treated surgically; later imaging raised concern for possible recurrence in the lung and rectal area, but lymph-node biopsy was clear and further workup was ongoing.

The Patient Story
OutcomeLiving With Cancer
Joe, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Joe's Patient Story

Patient Info: Joe, Male | Stage IV

Biomarkers: Specific biomarkers not reported

Metastatic Site: Liver; lymph nodes; lungs

Stage IV colon cancer initially reached no evidence of disease after FOLFOX plus panitumumab, but later recurred in the liver and lymph nodes, progressed to the lungs, and did not respond to later FOLFOX rechallenge or FOLFIRI before he started an immunotherapy clinical trial.

The Patient Story
OutcomeSetback / Progression